[if gte mso 9] > < xml >
a plant improvementsexual function in patients with benign prostatic hyperplasia
almost 12% ofmen older than 40 years has this condition
-A studypublished in May confirmed that the extract of Sabal serrulata reduces more ofhalf the urinary obstruction associated with pathology
-3 of every 4analyzed patients rated the effectiveness of this plant as a good or verygood ”
Madrid, June of2012- A research published inthe Journal Phytoterapy Research confirmsthe benefits of an extract of Sabal serrulata (Serenoa repens) in thetreatment of benign hyperplasia of prostate (BPH), and dysfunctionssexual partners. In particular, symptoms such as irritation and theobstruction of the urinary tract improved by more than 50 per cent; While thesexual problems (achieving and maintaining an erection, absence of)(sexual pleasure or ejaculation difficulties) were recovered in 40%, according tothe results of this multicenter observational study in Switzerlandwith more than 82 men with BPH and an average age of 57 years.
it is estimated thatalmost 12% of men older than 40 years suffer from this condition, apercentage that increases up to 30% in males over the age of 70,According to the latest epidemiological studies available in Spain. lossthe quality of life in these patients can have impact on the appearance of adeterioration in sexual desire and theerectile function in many cases ”, explains Concha Navarro, Professor ofPharmacology of the University of Granada and President of the Centre ofPhytotherapy research (INFIT).
is the first timea research joint on the effect of Sabal serrulata inThese two conditions and Hospital researchers have participated in itUniversity of Zurich (Switzerland) and the school of Pharmacy at the Universityof London. Patients who were recruited had at least moderate symptomsof BPH. During 8 weeks received a daily capsule of a prepared [i] with320 milligrams of berries of Sabal serrulata. After this period isvalidated questionnaires used to measure changes in hyperplasiabenign prostate (IPSS) and sexual function (bSFI and Urolife QoL-9). Thetypical symptoms of BPH, such as frequent, intense and urgent desire ofurinating for evenings, slow weak urine, urine flow Jet, sensationof residual urine, pressure on the bladder or residual after urination dripbe reduced by 51%, according to this trial.
sexual functionimproved by 40%. The problems to achieve and maintain an erection werethose who obtained better results (64% improvement), followed of theproblems associated with sexual desire and ejaculation (54%). The improvement ofthe quality of life of patients with BPH was 36%.
76% of thepatients and 82% of researchers surveyed rated the effectivenessglobal treatment as good or very good ”. On the best effect of thefloor, 66% said they have noticed substantial improvement in erectile function and thelibido jointly ”. Approximately 90% of patients and researchersthey would return to take or respectively indicate this treatment and 96% ratedthe tolerability of the product as good or very good ”.
conclusionsthe study indicate that extract Sabal serrulata is as effective as aalpha blocker or a 5-alpha-reductase inhibitor, both used asstandard treatment BPH ”. Unlike these drugs synthesisIt worsen the sexual dysfunction associated with BPH, a treatment with Sabalserrulata offers an effective result, but without this side effect,improving even sexual dysfunction , according to the authors of theresearch.
